Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Elsayed

Showing results (451-460 of 530) with videos related to

Pageof 53
Sort By:
Cureus|February 19, 2026
Preoperative Central Sensitization as a Predictor of Pain Outcomes After Hip and Knee Arthroplasty: A Systematic ReviewMajed S Alasbali, Yaser A Alshammari, Mohammed S Alhomaidi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 28, 2021
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancerWagdy M Eldehna, Rofaida Salem, Zainab M Elsayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 14, 2021
Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cellsMohammad M Al-Sanea, Ghada H Al-Ansary, Zainab M Elsayed, et al.
International Microbiology : the Official Journal of the Spanish Society for Microbiology|May 20, 2024
Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogensAbdulrahman E Koshak, Mahmoud A Elfaky, Dina A I Albadawi, et al.
RSC Advances|November 16, 2022
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogensTarfah Al-Warhi, Diaaeldin M Elimam, Zainab M Elsayed, et al.
Frontiers in Pharmacology|March 20, 2026
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityWagdy M Eldehna, Haytham O Tawfik, Denisa Veselá, et al.
Frontiers in Pharmacology|June 30, 2026
Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityWagdy M Eldehna, Haytham O Tawfik, Denisa Veselá, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 7, 2023
Organic acidurias in Egyptian children: The urge for high-risk screeningDina A Mehaney, Zeinab S Seliem, Laila A Selim, et al.
Bioorganic Chemistry|March 29, 2026
Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluationsZainab M Elsayed, Marwa Balaha, Haytham O Tawfik, et al.
Molecules (Basel, Switzerland)|April 13, 2023
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling InsightsTarfah Al-Warhi, Hadia Almahli, Raed M Maklad, et al.
Pageof 53

Showing results (451-460 of 530) with videos related to

Sort By:
Pageof 53
Cureus|February 19, 2026
Preoperative Central Sensitization as a Predictor of Pain Outcomes After Hip and Knee Arthroplasty: A Systematic ReviewMajed S Alasbali, Yaser A Alshammari, Mohammed S Alhomaidi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 28, 2021
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancerWagdy M Eldehna, Rofaida Salem, Zainab M Elsayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 14, 2021
Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cellsMohammad M Al-Sanea, Ghada H Al-Ansary, Zainab M Elsayed, et al.
International Microbiology : the Official Journal of the Spanish Society for Microbiology|May 20, 2024
Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogensAbdulrahman E Koshak, Mahmoud A Elfaky, Dina A I Albadawi, et al.
RSC Advances|November 16, 2022
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogensTarfah Al-Warhi, Diaaeldin M Elimam, Zainab M Elsayed, et al.
Frontiers in Pharmacology|March 20, 2026
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityWagdy M Eldehna, Haytham O Tawfik, Denisa Veselá, et al.
Frontiers in Pharmacology|June 30, 2026
Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activityWagdy M Eldehna, Haytham O Tawfik, Denisa Veselá, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 7, 2023
Organic acidurias in Egyptian children: The urge for high-risk screeningDina A Mehaney, Zeinab S Seliem, Laila A Selim, et al.
Bioorganic Chemistry|March 29, 2026
Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluationsZainab M Elsayed, Marwa Balaha, Haytham O Tawfik, et al.
Molecules (Basel, Switzerland)|April 13, 2023
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling InsightsTarfah Al-Warhi, Hadia Almahli, Raed M Maklad, et al.
Pageof 53